Development and Validation of a High- Performance Liquid Chromatography– Tandem Mass Spectrometry Method for the Simultaneous Determination of Irinotecan and Its Main Metabolites in Human Plasma and Its Application in a Clinical Pharmacokinetic Study
2015
2017-03-20 16:15:15
1033
Pharmacokinetic, pharmacodynamics, phase I clinical study, colorectal cancer, Mass spectrometry, pharmacogenetics
r6
Bianca
Posocco
70
Elisa
Mazzega
70
Elena
Marangon
70
Giuseppe
Toffoli
70
COBISS_ID
3
4724219
DOI
15
DOI:10.1371/journal.pone.0118194
NUK URN
18
URN:SI:UNG:REP:QU7X8ELA
Development_and_Validation.pdf
1042489
Predstavitvena datoteka
2017-03-20 16:42:14